This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Indridason, O. S. Articles by Quarles, L. D. Search for Related Content PubMed PubMed Citation Articles by Indridason, O. S. Articles by Quarles, L. D.

Predictors of Short-Term Changes in Serum Intact Parathyroid Hormone Levels in Hemodialysis Patients: Role of Phosphorus, Calcium, and Gender¹

Department of Medicine, Division of Nephrology, and the Division of Biometry, Department of Community and Family Health, Center for Aging and Human Development (C.F.P.), Duke University Medical Center, Durham, North Carolina 27713

Address all correspondence and requests for reprints to: Olafur S. Indridason, M.D., M.H.S., Department of Medicine, Box 3014, Duke University Medical Center, Durham, North Carolina 27713. E-mail: osi{at}acpub.duke.edu

Several factors have been identified as important in the pathogenesis of secondary hyperparathyroidism in end-stage renal disease, including serum calcium, phosphorus, and calcitriol. To examine the independent effects of key factors, we prospectively studied 52 new hemodialysis patients with mild secondary hyperparathyroidism (PTH, 110–670 pg/mL) treated with a standardized regimen of calcium supplements, phosphorus binders, and no vitamin D derivatives. We used simple and multivariable linear regression analysis to examine the relationship between changes in PTH (PTH) levels observed over a 4-week period and various biochemical and demographic variables. By simple linear regression we found that changes in serum phosphorus (r² = 0.31; ß = 41.6; P = 0.0001), initial phosphorus concentration (r² = 0.15; ß = 33.4; P = 0.005), initial PTH level (r² = 0.29; ß = 0.58; P = 0.0001), changes in serum calcium (r² = 0.12; ß = -74.0; P = 0.01), and gender (r² = 0.07; ß = 76.1; P = 0.05) were significantly associated with PTH. However, upon multivariable regression analysis, only the changes in phosphorus (partial r² = 0.31; ß = 37.0; P = 0.0001), initial PTH level (partial r² = 0.23; ß = 0.50; P = 0.0001), and gender (partial r² = 0.05; ß = 63.1; P = 0.02) remained significantly associated with PTH. Neither the serum concentration of 1,25-dihydroxyvitamin D₃, bicarbonate, aluminum, or albumin nor changes in the serum bicarbonate concentration, the presence of diabetes, KT/V, or age were significantly associated with the PTH. Our findings are consistent with independent effects of phosphorus and gender on parathyroid gland function in patients with dialysis-dependent renal failure through mechanisms that remain to be defined.

This article has been cited by other articles:

				C. Basile, C. Lomonte, L. Vernaglione, F. Casucci, D. Chimienti, A. Bruno, S. Cocola, E. A. Verrelli, and F. Cazzato A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uraemia Nephrol. Dial. Transplant., April 1, 2006; 21(4): 968 - 974. [Abstract] [Full Text] [PDF]